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INTRODUCTION
• Over the past twenty years, opioid usage has continued to rise significantly,
resulting in what many have termed an “opioid epidemic”.1-5
• Several studies have noted that patients are routinely over-prescribed opioids
following common surgical procedures, resulting in a large number of unused and
therefore readily-available opioid pills.6-8
• The highest reported age population for illicit drug usage is in individuals ages 2039 years old, which is the same group that commonly undergoes hip arthroscopy.910

• A previous study in patients undergoing arthroscopic rotator cuff repair
demonstrated that patients who received preoperative opioid education consumed
significantly less opioids 3 months after surgery than those patients who did not
receive the preoperative education.11
• The primary objective of this study was to investigate the effect that a preoperative opioid educational video has on patient’s opioid consumption following
hip arthroscopy procedures.

RESULTS
• Ninety-eight patients were included in the analysis (49 controls, 49 who received the
opioid education).
• There were no significant differences between the two groups in mean age at surgery,
BMI, or sex ratio. There were also no significant preoperative differences between the
two groups in patient reported function, as measured by SANE, or patient reported pain
and function as measured by MHHS (Table 1).
• Patients in the education group had a significantly higher median morphine milligram
equivalents (MME) consumed at 2 weeks. However, there was no significant difference
in the median MME consumed at 6 weeks or 12 weeks.
• When the two groups were compared, there were no significant differences in duration
of opioid consumption, as measured by the question “are you still taking narcotic
medication to control your hip pain”, or patient reported pain and function as reported by
the SANE scale and MHHS at 2 weeks, 6 weeks, and 12 weeks postoperatively.
• Power analysis revealed an effect size of 0.416 and power of 0.53 for mean MME
consumed at 2 weeks.
Table 1: Demographics

MATERIALS & METHODS
• This is a prospective, randomized trial enrolling patients undergoing arthroscopic hip
surgery for either isolated or concomitant labrum repair, acetabuloplasty, and/or
femoral osteoplasty.
• Exclusion criteria included a history of drug use, workman’s compensation, open
surgery, patients <18 years of age, and non-English speaking patients.
• Patients were randomly assigned in a 1:1 ratio to either be shown an educational
video detailing the risks of opioid utilization and dependence versus standard
protocol. All patients received the current standard protocol for managing postoperative discomfort (local anesthetic injection at the time of surgery [20cc of
ropivicaine peri-capsular], with 40 tablets of oxycodone 5mg/acetaminophen 325mg
given for post-operative pain).
• All prescriptions were monitored through the state prescription monitoring database
and correlated with patient reporting. Physicians who performed the surgical
procedure were blinded to which patients received patient education.
• Patients recorded their pain levels and opioid usage levels pre-operatively and then 2
weeks, 6 weeks, and 3 months after surgery. Included in each survey was the custom
narcotics use survey, along with the Modified Harris Hip Score (MHHS) and Single
Assessment Numeric Evaluation (SANE) rating. Number of opioid pills consumed was
converted to morphine milligram equivalents (MME) for statistical analysis.
• Parametric continuous data is presented as mean(SD) and p values were calculated
by performing T tests. Nonparametric continuous data is presented as Median [1st
quartile, 3rd quartile] and p values were calculated by performing Mann Whitney tests.
Post hoc tests were calculated using the Mean (SD) for significant values. P values
less than 0.05 were deemed significant. All statistical analyses were done using R
Studio (Version 3.6.3, Vienna, Austria).

Data is represented as Median [1st quartile; 3rd quartile] unless otherwise noted. BMI: Body Mass Index; SANE: Single Assessment Numerical Evaluation; MHHS: Modified
Harris Hip Score.

Table 2: Opioid Consumption

2 week MME
6 week MME
12 week MME

Education
Control
(n=49)
(n=49)
P value
65.0 [30.0; 112.0] 30.0 [0.00; 63.8] 0.013*
75.0 [45.0; 128.0] 35.0 [7.5; 135.0]
0.077
75.0 [52.5; 112.0] 41.2 [7.5; 148.0]
0.504

Data is represented as Median [1st quartile; 3rd quartile]. MME: Morphine milligram equivalents.
*Indicates statistically significant difference at P<0.05

DISCUSSION
While those who received the preoperative education module on opioid medications
actually demonstrated a higher median morphine milligram equivalents consumed in the
short term post-operative period at 2 weeks when compared to the control group, they did
not significantly differ from the control group at 6 or 12 weeks. Overall, the preoperative
education module had no apparent effect on patient-reported pain or function in the postoperative period following hip arthroscopy procedures.
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